Associate Professor Nick Lintzeris

Clinical Associate Professor
Addiction Medicine, Central Clinical School

Telephone 9515 6419

Map

Selected grants

2014

  • Randomised control trial of exercise for the management of cannabis withdrawal in adult humans; Lintzeris N, McGregor I, Rooney K, Allsop D, Arnold J; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • Randomised control trial of exercise for the management of cannabis withdrawal in adult humans; Lintzeris N; DVC Research/Bridging Support Grant.

2012

  • Health outcomes associated with long-term cannabis use; Johnston J, Lintzeris N, McGregor I; Health Administration Corporation/Drug and Alcohol Research Grant.

2009

  • The effects of mixing alcohol with presciption drugs upon driving performance: a randomised simulator study; Lintzeris N, Leung S, Lenne M, Haber P, Bruno R; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Randomised, double-blind, placebo controlled trial of lithium carbonate for the management of human cannabis withdrawal; Lintzeris N, McGregor I, Winstock A, Guastella A; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Haber, P., Lintzeris, N., Morley, K. (2009). Pharmacotherapies for alcohol dependence. In Paul Haber, Elizabeth Proude, Nick Lintzeris & Olga Lopatko (Eds.), Guidelines for the Treatment of Alcohol Problems, (pp. 93-106). Australia: Commonwealth of Australia.

Journals

  • Larance, B., Lintzeris, N., Ali, R., Dietze, P., Mattick, R., Jenkinson, R., White, N., Degenhardt, L. (2014). The diversion and injection of a buprenorphine-naloxone soluble film formulation. Drug and Alcohol Dependence, 136(1), 21-27. [More Information]
  • Lintzeris, N., Leung, S., Dunlop, A., Larance, B., White, N., Rivas, G., Holland, R., Degenhardt, L., Muhleisen, P., Hurley, M., et al (2013). A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence. Drug and Alcohol Dependence, 131(1-2), 119-126. [More Information]
  • Holliday, S., Magin, P., Dunbabin, J., Oldmeadow, C., Henry, J., Lintzeris, N., Attia, J., Goode, S., Dunlop, A. (2013). An Evaluation of the Prescription of Opioids for Chronic Nonmalignant Pain by Australian General Practitioners. Pain Medicine, 14(1), 62-74. [More Information]
  • Holliday, S., Magin, P., Oldmeadow, C., Attia, J., Dunbabin, J., Henry, J., Lintzeris, N., Goode, S., Dunlop, A. (2013). An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy. Drug and Alcohol Review, 32(5), 495-503. [More Information]
  • Nielsen, S., Larance, B., Lintzeris, N., Black, E., Bruno, R., Murnion, B., Dunlop, A., Degenhardt, L. (2013). Correlates of pain in an in-treatment sample of opioid-dependent people. Drug and Alcohol Review, 32(5), 489-494. [More Information]
  • Wong, A., Montebello, M., Norberg, M., Rooney, K., Lintzeris, N., Bruno, R., Booth, J., Arnold, J., McGregor, I. (2013). Exercise increases plasma THC concentrations in regular cannabis users. Drug and Alcohol Dependence, 133(2), 763-767. [More Information]
  • Nielsen, S., Bruno, R., Degenhardt, L., Stoove, M., Fischer, J., Carruthers, S., Lintzeris, N. (2013). The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids. Medical Journal of Australia, 199(10), 696-699. [More Information]
  • Groshkova, T., Metrebian, N., Hallam, C., Charles, V., Martin, A., Forzisi, L., Lintzeris, N., Strang, J. (2013). Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics. Drug and Alcohol Review, 32(6), 566-573. [More Information]
  • Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012). Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review, 31(4), 499-506. [More Information]
  • Black, K., Haber, P., Lintzeris, N. (2012). Offering incentives to drug-using women to take up contraception: The ethical and clinical issues. Addiction, 107(7), 1361-1362. [More Information]
  • Black, K., Stephens, C., Haber, P., Lintzeris, N. (2012). Unplanned pregnancy and contraceptive use in women attending drug treatment services. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52(2), 146-150. [More Information]
  • Winstock, A., Lintzeris, N., Lea, T. (2011). 'Should I stay or should I go?' Coming off methadone and buprenorphine treatment. International Journal of Drug Policy, 22(1), 77-81. [More Information]
  • Larance, B., Degenhardt, L., Lintzeris, N., Winstock, A., Mattick, R. (2011). Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug and Alcohol Review, 30(3), 236-245. [More Information]
  • Longman, C., Lintzeris, N., Temple-Smith, M., Gilchrist, G. (2011). Methadone and buprenorphine prescribing patterns of Victorian general practitioners: Their first 5 years after authorisation. Drug and Alcohol Review, 30(4), 355-359. [More Information]
  • Mayet, S., Gossop, M., Lintzeris, N., Markides, V., Strang, J. (2011). Methadone maintenance, QTc and torsade de pointes: Who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug and Alcohol Review, 30(4), 388-396. [More Information]
  • Nielsen, S., Bruno, R., Lintzeris, N., Fischer, J., Carruthers, S., StoovĂ©, M. (2011). Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia? Drug and Alcohol Review, 30(3), 291-299. [More Information]
  • Larance, B., Degenhardt, L., Lintzeris, N., Bell, J., Winstock, A., Dietze, P., Mattick, R., Ali, R., Horyniak, D. (2011). Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing. Drug and Alcohol Dependence, 118(2011), 265-273. [More Information]
  • Douglas, H., Boyle, M., Lintzeris, N. (2011). The health impacts of khat: a qualitative study among Somali-Australians. Medical Journal of Australia, 195(11), 666-669. [More Information]
  • Lintzeris, N., Nielsen, S. (2010). Benzodiazepines, methadone and buprenorphine: interactions and clinical management. American Journal on Addictions, 19(1), 59-72. [More Information]
  • Lintzeris, N. (2010). Commentary on Blanken et al. (2010): long-term heroin-assisted treatment-some more questions and answers. Addiction, 105(2), 309-310. [More Information]
  • Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010). Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review, 29(5), 469-474. [More Information]
  • Forzisi, L., Mitchell, T., Bond, A., Lintzeris, N., Spofforth, N., Strang, J. (2010). Psychological Performance and Sedation Following Injectable Opioid Administration. Heroin Addiction and Related Clinical Problems, 12(3), 5-8.
  • Miller, P., McKenzie, S., Lintzeris, N., Martin, A., Strang, J. (2010). The Community Impact of RIOTT, a Medically Supervised Injectable Maintenance Clinic in South London. Mental Health and Substance Use, 3(3), 248-259. [More Information]
  • Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010). The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction, 105(2), 329-334. [More Information]
  • Ridge, G., Gossop, M., Lintzeris, N., Witton, J., Strang, J. (2009). Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. Journal of Substance Abuse Treatment, 37(1), 95-100. [More Information]
  • Bammer,, G., Ritter, A., Kutin, J., Lintzeris, N. (2009). Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria. Australian and New Zealand Journal of Public Health, 33(1), 34-39. [More Information]
  • Miller, P., Forzisi, L., Zador, D., Lintzeris, N., Metrebian, N., Waal, R., Mayet, S., Strang, J. (2009). Groin injecting in injectable opioid treatment service users in South London. Addiction Research and Theory, 17(4), 381-389. [More Information]
  • Degenhardt, L., Larance, B., Bell, J., Winstock, A., Lintzeris, N., Ali, R., Scheuer, N. (2009). Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. Medical Journal of Australia, 191(3), 161-165. [More Information]
  • Lintzeris, N. (2009). Prescription of heroin for the management of heroin dependence: Current status. CNS Drugs, 23(6), 463-476. [More Information]
  • Winstock, A., Lintzeris, N., Lea, T. (2009). Why do patients report transferring between methadone and buprenorphine? Drug and Alcohol Review, 28(6), 686-687. [More Information]
  • Lintzeris, N., Lee, S., Scopelliti, L., Mabbutt, J., Haber, P. (2008). Unplanned admissions to two Sydney public hospitals after naltrexone implants. Medical Journal of Australia, 188(8), 441-444. [More Information]
  • Digiusto, E., Lintzeris, N., Breen, C., Kimber, J., Mattick, R., Bell, J., Ali, R., Saunders, J. (2005). Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project. Addictive Behaviors, 30(3), 443-56. [More Information]

Report

  • Haber, P., Lintzeris, N., Proude, E., Lopatko,, O. (2009). Guidelines for the Treatment of Alcohol Problems.

2014

  • Larance, B., Lintzeris, N., Ali, R., Dietze, P., Mattick, R., Jenkinson, R., White, N., Degenhardt, L. (2014). The diversion and injection of a buprenorphine-naloxone soluble film formulation. Drug and Alcohol Dependence, 136(1), 21-27. [More Information]

2013

  • Lintzeris, N., Leung, S., Dunlop, A., Larance, B., White, N., Rivas, G., Holland, R., Degenhardt, L., Muhleisen, P., Hurley, M., et al (2013). A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence. Drug and Alcohol Dependence, 131(1-2), 119-126. [More Information]
  • Holliday, S., Magin, P., Dunbabin, J., Oldmeadow, C., Henry, J., Lintzeris, N., Attia, J., Goode, S., Dunlop, A. (2013). An Evaluation of the Prescription of Opioids for Chronic Nonmalignant Pain by Australian General Practitioners. Pain Medicine, 14(1), 62-74. [More Information]
  • Holliday, S., Magin, P., Oldmeadow, C., Attia, J., Dunbabin, J., Henry, J., Lintzeris, N., Goode, S., Dunlop, A. (2013). An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy. Drug and Alcohol Review, 32(5), 495-503. [More Information]
  • Nielsen, S., Larance, B., Lintzeris, N., Black, E., Bruno, R., Murnion, B., Dunlop, A., Degenhardt, L. (2013). Correlates of pain in an in-treatment sample of opioid-dependent people. Drug and Alcohol Review, 32(5), 489-494. [More Information]
  • Wong, A., Montebello, M., Norberg, M., Rooney, K., Lintzeris, N., Bruno, R., Booth, J., Arnold, J., McGregor, I. (2013). Exercise increases plasma THC concentrations in regular cannabis users. Drug and Alcohol Dependence, 133(2), 763-767. [More Information]
  • Nielsen, S., Bruno, R., Degenhardt, L., Stoove, M., Fischer, J., Carruthers, S., Lintzeris, N. (2013). The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids. Medical Journal of Australia, 199(10), 696-699. [More Information]
  • Groshkova, T., Metrebian, N., Hallam, C., Charles, V., Martin, A., Forzisi, L., Lintzeris, N., Strang, J. (2013). Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics. Drug and Alcohol Review, 32(6), 566-573. [More Information]

2012

  • Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012). Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review, 31(4), 499-506. [More Information]
  • Black, K., Haber, P., Lintzeris, N. (2012). Offering incentives to drug-using women to take up contraception: The ethical and clinical issues. Addiction, 107(7), 1361-1362. [More Information]
  • Black, K., Stephens, C., Haber, P., Lintzeris, N. (2012). Unplanned pregnancy and contraceptive use in women attending drug treatment services. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52(2), 146-150. [More Information]

2011

  • Winstock, A., Lintzeris, N., Lea, T. (2011). 'Should I stay or should I go?' Coming off methadone and buprenorphine treatment. International Journal of Drug Policy, 22(1), 77-81. [More Information]
  • Larance, B., Degenhardt, L., Lintzeris, N., Winstock, A., Mattick, R. (2011). Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug and Alcohol Review, 30(3), 236-245. [More Information]
  • Longman, C., Lintzeris, N., Temple-Smith, M., Gilchrist, G. (2011). Methadone and buprenorphine prescribing patterns of Victorian general practitioners: Their first 5 years after authorisation. Drug and Alcohol Review, 30(4), 355-359. [More Information]
  • Mayet, S., Gossop, M., Lintzeris, N., Markides, V., Strang, J. (2011). Methadone maintenance, QTc and torsade de pointes: Who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug and Alcohol Review, 30(4), 388-396. [More Information]
  • Nielsen, S., Bruno, R., Lintzeris, N., Fischer, J., Carruthers, S., StoovĂ©, M. (2011). Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia? Drug and Alcohol Review, 30(3), 291-299. [More Information]
  • Larance, B., Degenhardt, L., Lintzeris, N., Bell, J., Winstock, A., Dietze, P., Mattick, R., Ali, R., Horyniak, D. (2011). Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing. Drug and Alcohol Dependence, 118(2011), 265-273. [More Information]
  • Douglas, H., Boyle, M., Lintzeris, N. (2011). The health impacts of khat: a qualitative study among Somali-Australians. Medical Journal of Australia, 195(11), 666-669. [More Information]

2010

  • Lintzeris, N., Nielsen, S. (2010). Benzodiazepines, methadone and buprenorphine: interactions and clinical management. American Journal on Addictions, 19(1), 59-72. [More Information]
  • Lintzeris, N. (2010). Commentary on Blanken et al. (2010): long-term heroin-assisted treatment-some more questions and answers. Addiction, 105(2), 309-310. [More Information]
  • Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010). Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review, 29(5), 469-474. [More Information]
  • Forzisi, L., Mitchell, T., Bond, A., Lintzeris, N., Spofforth, N., Strang, J. (2010). Psychological Performance and Sedation Following Injectable Opioid Administration. Heroin Addiction and Related Clinical Problems, 12(3), 5-8.
  • Miller, P., McKenzie, S., Lintzeris, N., Martin, A., Strang, J. (2010). The Community Impact of RIOTT, a Medically Supervised Injectable Maintenance Clinic in South London. Mental Health and Substance Use, 3(3), 248-259. [More Information]
  • Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010). The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction, 105(2), 329-334. [More Information]

2009

  • Ridge, G., Gossop, M., Lintzeris, N., Witton, J., Strang, J. (2009). Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. Journal of Substance Abuse Treatment, 37(1), 95-100. [More Information]
  • Bammer,, G., Ritter, A., Kutin, J., Lintzeris, N. (2009). Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria. Australian and New Zealand Journal of Public Health, 33(1), 34-39. [More Information]
  • Miller, P., Forzisi, L., Zador, D., Lintzeris, N., Metrebian, N., Waal, R., Mayet, S., Strang, J. (2009). Groin injecting in injectable opioid treatment service users in South London. Addiction Research and Theory, 17(4), 381-389. [More Information]
  • Haber, P., Lintzeris, N., Proude, E., Lopatko,, O. (2009). Guidelines for the Treatment of Alcohol Problems.
  • Degenhardt, L., Larance, B., Bell, J., Winstock, A., Lintzeris, N., Ali, R., Scheuer, N. (2009). Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. Medical Journal of Australia, 191(3), 161-165. [More Information]
  • Haber, P., Lintzeris, N., Morley, K. (2009). Pharmacotherapies for alcohol dependence. In Paul Haber, Elizabeth Proude, Nick Lintzeris & Olga Lopatko (Eds.), Guidelines for the Treatment of Alcohol Problems, (pp. 93-106). Australia: Commonwealth of Australia.
  • Lintzeris, N. (2009). Prescription of heroin for the management of heroin dependence: Current status. CNS Drugs, 23(6), 463-476. [More Information]
  • Winstock, A., Lintzeris, N., Lea, T. (2009). Why do patients report transferring between methadone and buprenorphine? Drug and Alcohol Review, 28(6), 686-687. [More Information]

2008

  • Lintzeris, N., Lee, S., Scopelliti, L., Mabbutt, J., Haber, P. (2008). Unplanned admissions to two Sydney public hospitals after naltrexone implants. Medical Journal of Australia, 188(8), 441-444. [More Information]

2005

  • Digiusto, E., Lintzeris, N., Breen, C., Kimber, J., Mattick, R., Bell, J., Ali, R., Saunders, J. (2005). Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project. Addictive Behaviors, 30(3), 443-56. [More Information]

To update your profile click here. For support on your academic profile contact .